β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma

BACKGROUND: The use of β-blockers for the management of hypertension has been recently associated with significant clinical benefits in cancer patients. Herein, we investigated whether β-blockers could be used in combination with chemotherapy for the treatment of neuroblastoma. METHODS: Seven β-bloc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquier, E, Street, J, Pouchy, C, Carre, M, Gifford, A J, Murray, J, Norris, M D, Trahair, T, Andre, N, Kavallaris, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694229/
https://www.ncbi.nlm.nih.gov/pubmed/23695022
http://dx.doi.org/10.1038/bjc.2013.205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694229/
https://www.ncbi.nlm.nih.gov/pubmed/23695022
http://dx.doi.org/10.1038/bjc.2013.205

Ejemplares similares